Role and mechanism of Roux-en-Y gastric bypass in the treatment of diabetic urinary bladder hyperactivity by reducing TRPV1 and P2X3

doi:10.4239/wjd.v16.i4.96176

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-8)

Tables (1-2)

Sum=0

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Apr 15, 2025 (publication date) through Feb 28, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Apr 15, 2025; 16(4): 96176
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.96176

Full Size Figure Download Figure

Figure 2 Urine stain test results in mice. A: Representative image for void spot assay analysis, B: Urine spot count; C: Total area of urine spot; D: The ratio of urine spot area in central area. All the statistical results were expressed as mean ± SD (n = 8). ^aP < 0.05, overactive bladder (OAB) compared with the sham group; ^bP < 0.05, Roux-en-Y gastric bypass (RYGB) compared with the OAB group.

Citation: Li GY, Ren S, Huang BC, Feng JJ, Wang QQ, Peng QJ, Tian HF, Yu LY, Ma CL, Fan SZ, Chen XJ, Al-Qaisi MA, He R. Role and mechanism of Roux-en-Y gastric bypass in the treatment of diabetic urinary bladder hyperactivity by reducing TRPV1 and P2X3. World J Diabetes 2025; 16(4): 96176
URL: https://www.wjgnet.com/1948-9358/full/v16/i4/96176.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i4.96176